Erythropoietin Receptor Antibodies

Santa Cruz Biotechnology features a diverse variety of Erythropoietin Receptor monoclonal antibodies for various research applications. Erythropoietin Receptor Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The erythropoietin receptor plays a critical role in erythropoiesis, the process of red blood cell production, by mediating the effects of erythropoietin, a hormone that stimulates the formation of red blood cells in the bone marrow. Understanding the function of the Erythropoietin Receptor is essential for studying various hematological disorders and conditions related to oxygen transport in the body. Aberrations in erythropoietin receptor signaling can contribute to diseases such as anemia and certain cancers, making research in this area particularly significant. Erythropoietin Receptor monoclonal antibodies enable detailed investigation of cellular pathways and molecular mechanisms involved in red blood cell development. Researchers can utilize specific antibody conjugates, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), for enhanced detection and visualization. Santa Cruz Biotechnology monoclonal antibodies for Erythropoietin Receptor support researchers worldwide in advancing our understanding of hematological diseases and potential therapeutic approaches.